Latest Health News

Tag: protein

  • Sanofi, Regeneron lose bid to overturn Amgen win in patent case

    —

    by

    elegant
    in

    A federal judge on Tuesday refused to throw out a court verdict upholding two Amgen Inc patents related to the company's cholesterol drug, a defeat for Sanofi SA and Regeneron Pharmaceuticals Inc, which make a rival drug. In an October 2014 lawsuit, Amgen had sought to stop Paris-based Sanofi and Tarrytown, New York-based Regeneron from…

  • Omega-3 fatty acids linked to lower risk of heart disease

    —

    by

    admin
    in

    By Lisa Rapaport (Reuters Health) – Omega-3 fatty acids in fish and dietary supplements are associated with lower odds of heart disease even in people already at elevated risk because of excessive levels of fats or bad cholesterol in their blood, a research review suggests. The American Heart Association recommends eating at least two servings…

  • Roche says FDA fast tracks atezolizumab in specific type of lung cancer

    —

    by

    admin
    in

    Roche Holding AG said on Monday the U.S. Food and Drug Administration has granted priority review for atezolizumab for treating people with a specific type of lung cancer. The designation covers treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease expresses the protein PD-L1 as determined by an FDA-approved…

  • Breed-your-own insect ‘revolution’ for the kitchen

    —

    by

    creative
    in

    Katharina Unger and Julia Kaisinger, 25 and 28, have developed a device to breed in the comfort of your own home the protein-rich grubs of the meal beetle, to then eat. “The first step is mentally to get over the fact that you are eating an insect.

  • Conatus liver drug shows promise in mid-stage trial

    —

    by

    creative
    in

    (Reuters) – Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial. The drug, emricasan, showed a statistically significant reduction in the protein fragment, caspase-cleaved cytokeratin 18 (cCK18), when compared with a placebo, in the overall patient population, according to the three-month…

  • Conatus liver drug shows promise in mid-stage trial

    —

    by

    contributor
    in

    (Reuters) – Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial. The drug, emricasan, showed a statistically significant reduction in the protein fragment, caspase-cleaved cytokeratin 18 (cCK18), when compared with a placebo, in the overall patient population, according to the three-month…

  • Valeant plans to appoint new CEO as Pearson remains hospitalized: WSJ

    —

    by

    admin
    in

    (Reuters) – Valeant Pharmaceuticals International Inc is planning to appoint a new CEO as Chief Executive Michael Pearson remains hospitalized, the Wall Street Journal said, citing people familiar with the matter. The new chief executive would replace the committee currently running the company, the newspaper said. Potential new chief executive candidates include Chief Financial Officer…